Related Experiment Videos
Clozapine and weight gain
D S Umbricht1, S Pollack, J M Kane
1Hillside Hospital, Psychiatry Research Department, Glen Oaks, N.Y. 11004.
The Journal of Clinical Psychiatry
|September 1, 1994
Summary
Clozapine treatment in schizophrenia patients frequently causes significant weight gain, often exceeding 50% incidence, which may pose long-term health risks. This weight gain is not linked to treatment response.
Area of Science:
- Psychiatry
- Pharmacology
- Metabolic Health
Background:
- Clozapine is an atypical antipsychotic used for treatment-resistant schizophrenia.
- Weight gain is a known side effect of clozapine, but its extent and long-term implications require further investigation.
Purpose of the Study:
- To examine the association between clozapine treatment and weight gain in patients with chronic schizophrenia.
- To assess short- and long-term weight changes, their correlation with treatment response, and risk factors for weight gain.
Main Methods:
- Retrospective chart review of weight data from 82 patients with chronic schizophrenia.
- Clozapine dosage titration (500-600 mg/day) over 3-5 weeks.
- Psychopathology assessed using the Brief Psychiatric Rating Scale and Clinical Global Impressions scale.
Main Results:
- Clinically significant weight gain occurred primarily within the first 6-12 months, continuing into the third year.
- Over 50% of patients became substantially overweight.
- Weight gain did not correlate with treatment response; early weight gain was not predictive of response.
- Baseline underweight status correlated with maximum weight gain, while baseline overweight status correlated with percentage above ideal weight.
Conclusions:
- Clozapine treatment is associated with a high incidence of substantial weight gain, presenting a potential long-term health risk.
- Further research is needed to understand the mechanisms of clozapine-induced weight gain and develop effective treatments for this adverse effect.